pyrazines has been researched along with Congenital Zika Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Ho, YJ; Huang, CK; Lin, KC; Lu, JW | 1 |
| Behillil, S; Chapon, C; Contreras, V; de Lamballerie, X; Delache, B; Dereuddre-Bosquet, N; Desjardins, D; Guedj, J; Ho Tsong Fang, R; Kahlaoui, N; Le Grand, R; Lemaitre, J; Lingas, G; Ludot, C; Maisonnasse, P; Malvy, D; Marlin, R; Naninck, T; Nougairede, A; Pascal, Q; Pizzorno, A; Relouzat, F; Roques, P; Rosa Calatrava, M; Solas, C; Terrier, O; van der Werf, S | 1 |
| Chan, CCS; Chan, JFW; Chik, KKH; Chu, H; Kok, KH; Poon, VKM; Shuai, H; Wang, Y; Yang, D; Yin, F; Yuan, S; Yuen, KY; Yuen, TTT; Zhou, J; Zhu, Z; Zou, Z | 1 |
| Ferreon, J; Hua, Y; Huo, T; Kneubehl, AR; Lin, YL; Nie, S; Rico-Hesse, R; Song, Y; Vogt, MB; Wu, F; Wu, J; Wu, X; Yao, Y; Zhao, J | 1 |
| Aliota, MT; Bonnac, LF; Geraghty, RJ | 1 |
| Baz, M; Boivin, G; Goyette, N; Griffin, BD; Kobinger, GP | 1 |
| Brown, AN; Bulitta, JB; Kim, TH; Pires de Mello, CP; Pomeroy, JJ; Rodriquez, JL; Tao, X | 1 |
| Kim, JA; Kumar, M; Seong, RK; Shin, OS | 1 |
| Arias, A; Bassi, MR; Meyn, P; Polacek, C; Sempere, RN | 1 |
| Brown, AN; Bulitta, JB; Kaushik, A; Kim, TH; Pires de Mello, CP; Tao, X; Vicchiarelli, M | 1 |
| Hua, Y; Huo, T; Kneubehl, AR; Lin, YL; Nie, S; Rico-Hesse, R; Song, Y; Vogt, MB; Wu, F; Wu, J; Yao, Y | 1 |
1 review(s) available for pyrazines and Congenital Zika Syndrome
| Article | Year |
|---|---|
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Mutagenesis; Nucleosides; Pyrazines; Ribavirin; SARS-CoV-2; Virus Replication; Zika Virus; Zika Virus Infection | 2021 |
10 other study(ies) available for pyrazines and Congenital Zika Syndrome
| Article | Year |
|---|---|
Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection.
Topics: Anidulafungin; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Synergism; Humans; Inhibitory Concentration 50; Pyrazines; RNA, Viral; Vero Cells; Virion; Virus Attachment; Zika Virus; Zika Virus Infection | 2021 |
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Topics: Amides; Animals; Antiviral Agents; COVID-19 Drug Treatment; Humans; Macaca fascicularis; Pandemics; Primates; Pyrazines; SARS-CoV-2; Zika Virus; Zika Virus Infection | 2022 |
Targeting the Inositol-Requiring Enzyme-1 Pathway Efficiently Reverts Zika Virus-Induced Neurogenesis and Spermatogenesis Marker Perturbations.
Topics: Humans; Imidazoles; Inositol; Naphthalenes; Neurogenesis; Protein Serine-Threonine Kinases; Pyrazines; Spermatogenesis; Zika Virus; Zika Virus Infection | 2020 |
Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
Topics: Allosteric Regulation; Animals; Antiviral Agents; Cell Line, Tumor; Dengue Virus; Humans; Mice; Molecular Structure; Pyrazines; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Viral Nonstructural Proteins; Viral Proteins; Virus Replication; West Nile virus; Zika Virus; Zika Virus Infection | 2021 |
In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.
Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Synergism; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrazines; Ribavirin; Spatio-Temporal Analysis; Vero Cells; Zika Virus; Zika Virus Infection | 2017 |
Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; DNA Replication; Humans; Interferon-alpha; Pyrazines; Ribavirin; Vero Cells; Viral Load; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |
Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Topics: Amides; Animals; Antiviral Agents; Apoptosis; Cell Line; Cell Proliferation; Chlorocebus aethiops; Humans; Pyrazines; Ribavirin; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |
Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Epithelial Cells; Flavivirus; Fluorouracil; Mutagenesis; Mutagens; Mutation Rate; Nucleosides; Pyrazines; Ribavirin; Ribonucleosides; Serial Passage; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |
Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Humans; Models, Theoretical; Pyrazines; Vero Cells; Viral Load; Virus Replication; Zika Virus; Zika Virus Infection | 2018 |
Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
Topics: Allosteric Site; Aminopyridines; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Crystallography, X-Ray; Dengue Virus; Drug Discovery; Female; Humans; Male; Mice, Inbred C57BL; Protease Inhibitors; Protein Binding; Pyrazines; Serine Endopeptidases; Vero Cells; Viral Nonstructural Proteins; Viral Proteins; West Nile virus; Zika Virus; Zika Virus Infection | 2019 |